ID   SHOV4
AC   CVCL_XJ63
DR   CCRID; 4201PAT-CCTCC01300
DR   Wikidata; Q98132544
RX   Patent=CN109486767B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018195.
CC   Population: Chinese; Han.
CC   Doubling time: ~48 hours (Patent=CN109486767B).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Patent=CN109486767B
ST   Amelogenin: X
ST   CSF1PO: 10,11,12
ST   D12S391: 21,22
ST   D13S317: 8,11,12
ST   D16S539: 11,12
ST   D18S51: 15,16,17
ST   D19S433: 14,14.2
ST   D21S11: 29,30,31.2
ST   D2S1338: 18,23
ST   D3S1358: 14
ST   D5S818: 10,11
ST   D6S1043: 12
ST   D7S820: 13,14
ST   D8S1179: 14,15
ST   FGA: 24,25
ST   Penta D: 12,13
ST   Penta E: 5,13
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 8
//
RX   Patent=CN109486767B;
RA   Xiao Y.-Z., Zhang R., Yu Y., Wang Y.-D., Li Y.-H., Wang C., Du B.,
RA   Liu M.-Y.;
RT   "Human epithelial ovarian cancer cell SHOV4 and application thereof.";
RL   Patent number CN109486767B, 16-Jul-2021.
//